LIVN - The Value Lab Portfolio Eclipses Benchmarks At 28% YoY And 24% YTD Growth
- Our portfolio has eclipsed all benchmarks both on a YoY and YTD basis with our contrarian, obscure stock and mid-cap approach with an exaggerated risk aversion.
- We discuss the logic behind our general style and why it is structurally advantaged against indices, and how it contributed to our 25% CAGR over the last 6 years.
- We also discuss portfolio strategy and theme on a go-forward basis, revealing our exclusive portfolio with rationales now that we are 0% cash.
- We open our book to SA readers and invite a forum to get feedback on our ideas and concepts.
For further details see:
The Value Lab Portfolio Eclipses Benchmarks At 28% YoY, And 24% YTD Growth